about
A marginal structural model for multiple-outcome survival data:assessing the impact of injection drug use on several causes of death in the Canadian Co-infection Cohort.The Gap Procedure: for the identification of phylogenetic clusters in HIV-1 sequence data.The transcriptional regulator CBP has defined spatial associations within interphase nuclei.Quantitative analysis of cell nucleus organisation.Segmentation of fluorescence microscopy images for quantitative analysis of cell nuclear architecture.Bayesian coclustering of Anopheles gene expression time series: study of immune defense response to multiple experimental challenges.Analysis of spatial point patterns in nuclear biologyPersonalized versus standardized dosing strategies for the treatment of childhood amblyopia: study protocol for a randomized controlled trial.Assessment of Overlap of Phylogenetic Transmission Clusters and Communities in Simple Sexual Contact Networks: Applications to HIV-1.Reductions in intestinal Clostridiales precede the development of nosocomial Clostridium difficile infection.Treatment of Amblyopia Using Personalized Dosing Strategies: Statistical Modelling and Clinical Implementation.Model validation and selection for personalized medicine using dynamic-weighted ordinary least squares.New quantitative approaches reveal the spatial preference of nuclear compartments in mammalian fibroblasts.Large cluster outbreaks sustain the HIV epidemic among men having sex with men (MSM) in Quebec from 2002 to 2015.Treatment Prediction, Balance, and Propensity Score Adjustment.Model assessment in dynamic treatment regimen estimation via double robustness.Optimal individualized dosing strategies: A pharmacologic approach to developing dynamic treatment regimens for continuous-valued treatments.An R Package for G-estimation of Structural Nested Mean Models.Discussion of "Deductive derivation and turing-computerization of semiparametric efficient estimation" by Frangakis et al.Objectively monitored patching regimens for treatment of amblyopia: randomised trial.On Bayesian estimation of marginal structural models.Predictive Bayesian inference and dynamic treatment regimes.Rejoinder "On Bayesian estimation of marginal structural models".Propensity Score Estimation in the Presence of Length-biased Sampling: A Nonparametric Adjustment ApproachCardiac tissue velocities and strain rate in the early detection of myocardial dysfunction of asymptomatic boys with Duchenne's muscular dystrophy: relationship to clinical outcome.Erratum to: Linear growth faltering in infants is associated with Acidaminococcus sp. and community-level changes in the gut microbiota.hGH isoform differential immunoassays applied to blood samples from athletes: decision limits for anti-doping testing.Compliance with occlusion therapy for childhood amblyopia.Triiodothyronine stimulates food intake via the hypothalamic ventromedial nucleus independent of changes in energy expenditure.Age-related changes in oxygen saturation over the first year of life: a longitudinal study.Bayesian adaptive trials for rare cardiovascular conditions.Simulating sequential multiple assignment randomized trials to generate optimal personalized warfarin dosing strategies.Treatment of unilateral amblyopia: factors influencing visual outcome.Treatment dose-response in amblyopia therapy: the Monitored Occlusion Treatment of Amblyopia Study (MOTAS).Bayesian analysis of quasi-life tables.Modeling dose-response in amblyopia: toward a child-specific treatment plan.Estimating multipoint recombination fractions.Bayesian inference in multipoint gene mapping.DM-PhyClus: a Bayesian phylogenetic algorithm for infectious disease transmission cluster inferenceAssessing the role of transmission chains in the spread of HIV-1 among men who have sex with men in Quebec, Canada
P50
Q30700708-D7157370-B1EF-49DD-AECE-966F809EDF6FQ31018138-21F5C847-543F-4B6B-8864-28332663B081Q33260998-1C0AC696-1401-4E18-BE8C-DF43BD93B2E1Q33293161-475E34B2-E7CF-476D-9FD0-FA61E78E93B1Q33433305-521148FB-4B1E-4277-BD2C-566D4EF0E2F5Q34144499-F5B9A4BC-064C-470E-87B3-BC5D00286D2EQ34277440-0074E6E9-5410-480E-A29D-9542416EF1F7Q35552835-944DCE02-24DD-4853-BB53-9FEDF165C85CQ35919781-C9E671C9-5050-44D5-9864-3DABFA317210Q37677347-B8B3E145-F457-42C8-80E3-F52283A9DD4FQ38785756-A3422C6A-0EF8-4EBE-8FD2-6BE1CCBE431AQ38795522-3A3322B6-23CE-40B2-BA1A-E6FFF4A81C2EQ38915472-56220BF3-FE86-4860-9403-D435B0F35092Q38920691-0F13DD68-9E48-41ED-9F76-BD74360254A5Q40097927-A1DB159C-5187-4036-B395-1E2357C9D65DQ40118737-8C8E20BC-6EBE-4B60-8DE9-2354F63AB058Q40355800-483AFB03-A014-44A7-8379-8B30869ED249Q40486356-50CB16C3-F9E5-4611-A3B6-C3ED683D8717Q40538369-B91F10AE-0C6B-497B-AB84-E4C5D1B12FCCQ41131966-B1908DD0-0666-451F-B371-CB11A3AA0178Q41442884-604141AF-B688-4325-80FA-08CD9D8FA48EQ41496836-DA38CB9D-89D4-4B99-8663-B3546E2CA60DQ41503229-CC7D722F-5A39-4043-B578-0C3302B57842Q41898042-CA5475AD-3B51-4CE1-A19E-745D765A92DDQ42833726-822D7DC5-F1B1-45CA-961F-9CBB101BD812Q43072120-8A298B12-AA77-4CDA-9410-8E00F9C21B3AQ43816745-25DD1C48-BDED-4979-9433-346513B8C36FQ44710915-A4806BBA-1846-4845-927C-DDAEFA17C68EQ45009181-3A77D75D-965E-4510-A42B-0437203E2432Q48832437-76264C48-191E-4B1D-99C1-438D358945BDQ50192532-C12AF07E-EBD0-4290-8A05-4D2BA3AF7BC6Q50693478-2EF80BB3-A113-4506-9AE8-86B724E1EC16Q51365724-82B81ED2-5FC8-40D9-8EEE-341B564CFC1CQ51628257-B2EC409B-31E2-42C0-B213-C763503F66D7Q51629661-F79574D7-E927-43A7-8AEC-7341CBA48C1EQ51913861-CC950F34-DAA7-421F-90A3-9C6F323464EBQ52338119-B8A5E4B3-60E2-40FD-A66B-9A3EB9A3B51DQ52405698-0C951B7B-5E7B-47C3-9464-E10EF70F3133Q57157111-D637166D-165A-42A1-BDEB-F55942A8A8C2Q64058710-B29B7214-B9B9-4D99-BAD4-C2BA6CDAF380
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
David A Stephens
@ast
David A Stephens
@en
David A Stephens
@es
David A Stephens
@nl
type
label
David A Stephens
@ast
David A Stephens
@en
David A Stephens
@es
David A Stephens
@nl
prefLabel
David A Stephens
@ast
David A Stephens
@en
David A Stephens
@es
David A Stephens
@nl
P1153
7402939693
P31
P496
0000-0001-9811-7140